Opioid Use Disorder
Cluster Number:
Wiki Number: PW144
Diagnosis: Opioid Use Disorder
US Patients: About 27 million in 2016
World Patients:
Sex Ratio: M+;F
Age Onset: Young adults
Brain Area: Opioids reduce dopamine in nucleus accumbens. Neuroimaging affects in the orbitofrontal area-reducing reward-behaviors
Symptoms: strong desire to use oioids, tolerance, withdrawal symptoms & living normal lives; most US heroin users began with prescriptions
Progression: Long term use shows dysregulation of brain circuits for emotion, distress and high impulsivity.
Causes:
Medications: opioid replacement threrapy uses methadone or buprenophine and naltrexone; heroin withdrawal symptoms from 2 days-2 weeks
Therapies: CBT; Lohr’s “Calming My Pain!” (DVD or Download from this website) helps to retrain the brain to reduce pain without opioids.
Youtube Video:Here’s Why Opioid Addiction Is So Intense
Amazon or Library Book: Decisions In Recovery:
Treatment for Opioid Use Disorder
Click the text to click or buy from Amazon.
samhsa.gov; 800-662-4357
(U.S. Substance Abuse and Mental Services Administration Help)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Expanding the opioid use disorder medication treatment workforce in rural communities through the RCORP initiativeby C Holly A Andrilla on July 26, 2024
CONCLUSIONS: Study findings suggest that federal investments to expand rural OUD patients' access to care may have been successful, but only if increases in clinician supply translate into greater provision of OUD treatment.
- Adherence to buprenorphine-XR through hybrid telehealth contingency management procedures: a case seriesby Jay A Gorman on July 26, 2024
CONCLUSIONS: This is a novel method of CM implementation. HTCM streamlined the process and was successful in increasing accessibility, reducing time-burden on patients and staff, while preserving fidelity to key components of the model. Considerations for future implementation and implications of HTCM are discussed.
- Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosisby Paul J Christine on July 26, 2024
CONCLUSIONS AND RELEVANCE: This study found that nearly 1 in 3 individuals experience insurance transitions in the 12 months after OUD diagnosis. Insurance transitions may represent an important yet underrecognized factor in OUD treatment outcomes.
- Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenariosby Eric Tatara on July 26, 2024
Access to treatment and medication for opioid use disorder (MOUD) is essential in reducing opioid use and associated behavioral risks, such as syringe sharing among persons who inject drugs (PWID). Syringe sharing among PWID carries high risk of transmission of serious infections such as hepatitis C and HIV. MOUD resources, such as methadone provider clinics, however, are often unavailable to PWID due to barriers like long travel distance to the nearest methadone provider and the required...